A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes.

A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

By Dani Blum I’ve reported on Ozempic since 2022 ... Patients may need a liver transplant, or can die from the disease. Novo Nordisk has asked the Food and Drug Administration to approve ...

Ozempic is now the only GLP-1 receptor agonist proven to reduce the risk of chronic kidney disease and people living with type 2 diabetes and chronic kidney disease. Novo Nordisk remains the ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

A Maryland man with diabetes is suing Novo Nordisk, alleging that semaglutide ... heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS) inhibitors ...

In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...

Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 - covering burden, and the value of treatment and prevention ...

Related FDA warns of fake Ozempic Type 2 diabetes injection drugs Evidence grows that Ozempic can curb alcoholism GLP-1 medications show promise in slowing kidney disease progression MASH occurs ...

In his suit, Todd Engel, of Howard County, accused Novo Nordisk Inc. and 10 other ... for the treatment of diabetes and chronic kidney disease. However, it is often prescribed or used for weight ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...